|
|
| | SPHINX31 Basic information |
| Product Name: | SPHINX31 | | Synonyms: | SPHINX31;CS-2837;2-Furancarboxamide, 5-(4-pyridinyl)-N-[2-[4-(2-pyridinylmethyl)-1-piperazinyl]-5-(trifluoromethyl)phenyl]-;N-(2-(4-(Pyridin-2-ylmethyl)piperazin-1-yl)-5-(trifluoromethyl)phenyl)-5-(pyridin-4-yl)furan-2-carboxamide;Serine-arginine protein kinases,retinal permeability,eye disease,neovascular,Inhibitor,Norway Brown rats,SPHINX 31,SRPK,SPHINX31,inhibit,Vascular endothelial growth factor receptor,HuCCA-1,VEGFR,SPHINX-31,diabetics,angiogenic | | CAS: | 1818389-84-2 | | MF: | C27H24F3N5O2 | | MW: | 507.51 | | EINECS: | | | Product Categories: | | | Mol File: | 1818389-84-2.mol |  |
| | SPHINX31 Chemical Properties |
| Boiling point | 569.0±50.0 °C(Predicted) | | density | 1.342±0.06 g/cm3(Predicted) | | storage temp. | under inert gas (nitrogen or Argon) at 2-8°C | | solubility | DMSO:17.5(Max Conc. mg/mL);34.48(Max Conc. mM)
Ethanol:12.0(Max Conc. mg/mL);23.65(Max Conc. mM) | | form | A crystalline solid | | pka | 11.83±0.70(Predicted) |
| | SPHINX31 Usage And Synthesis |
| | SPHINX31 Preparation Products And Raw materials |
|